Paul Little

Paralegal Specialist

I enjoy the fact that we get to work with our clients on a common goal – to help them achieve maximum success.

Paul Little is a paralegal specialist in the emerging companies practice group and a member of Cooley's business department.  He joined Cooley in 2007 and has 25+ years of experience in working with emerging growth companies in a variety of corporate and securities transactions, including venture capital financings, public offerings, corporate maintenance and mergers and acquisitions.

Download full bio 


  • Cooley advises Inflammatix on $102M Series D Round 

  • Avidity Biosciences – $100 Million Series C 

  • NGM Biopharmaceuticals - $107 Million IPO 

  • Spruce Biosciences – $130 Million IPO 


    Avid golfer

    Traveling with my wife

    Family time


  • University of California, Davis
    BA, History

  • St. Mary's College
    PLCERT, 1991

Media & Insight